HKSTP Teams Up with HKU and CUHK Medical Schools to Showcase Hong Kong's Life & Health Innovations at BIO International Convention
Seizing Global Business and Investment Opportunities for Sustainable Growth
In collaboration with InvestHK, HKSTP joined forces with the LKS Faculty of Medicine at The University of Hong Kong (HKU) and the Faculty of Medicine at The Chinese University of Hong Kong (CUHK) for the first time to form a delegation and led 16 prominent life and health technology companies to showcase at BIO 2025 held in Boston, USA.
Immuno Cure , partnering with HKUMed, the developer of the first-in-human novel therapeutic HIV vaccine ICVAX, announced its collaboration with PharmaJet to explore the application of a needle-free vaccination solution, accelerating the global commercialization pathway for ICVAX.
, partnering with HKUMed, the developer of the first-in-human novel therapeutic HIV vaccine ICVAX, announced its collaboration with PharmaJet to explore the application of a needle-free vaccination solution, accelerating the global commercialization pathway for ICVAX. HKSTP signed a partnership agreement with DLRC to provide legal advisory services in clinical trials and certification, promoting global ecosystem collaboration and growth.
Allegrow Biotech Limited ARBELE Limited Beth Bioinformatics Co., Limited Centre for Translational Stem Cell Biology The Centre for Virology, Vaccinology, and Therapeutics DECODE CURE Limited GenEditBio Limited Great Bay Bio Hong Kong Universal Biologicals Company Limited Immuno Cure Holding (HK) Limited The Institute for Innovation, Translation and Policy Research (ITPR) LEE'S PHARMACEUTICAL (HK) LIMITED Serilink Biotechnology Company Limited Xiaomo Biotech Limited XUXIN (HongKong) Biotechnology Co., Limited Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Limited
HONG KONG SAR - Media OutReach Newswire - 17 June 2025 - Hong Kong Science and Technology Parks Corporation (HKSTP), in collaboration with InvestHK, led 16 prominent life and health technology companies to BIO 2025, the world's largest biotechnology event, held in Boston, USA, from June 16 to 19. This year marks the first time HKSTP joined forces with Hong Kong's two leading medical faculties—theto form a delegation, showcasing Hong Kong's cutting-edge research capabilities and innovation potential in life sciences and health technologies. The initiative further strengthens Hong Kong's position as a world-class biotech innovation hub.The HKSTP Pavilion highlighted the groundbreaking technologies and products of its park companies, featuring innovative solutions across diverse fields such as novel drug development, diagnostic technologies, and medical innovation. Among the 16 participating companies, they were the members of HKSTP's incubation programmes including Incu-Bio and ELITE Programme, cutting-edge work from the InnoHK research centers, and other outstanding biotech companies. On the first day of the exhibition, the delegation successfully attracted attention from global industry leaders, corporate partners, and venture capital firms.During BIO 2025, HKSTP and its park companies made significant strides in fostering cross-border innovation ecosystems and exploring new market opportunities:, said: "We are thrilled to partner with two leading medical schools for the first time at BIO 2025, demonstrating Hong Kong's breakthroughs and innovation in life and health technology. This delegation not only deepens collaboration between Hong Kong and top global research institutions but also highlights our unique advantages as a core I&T hub in the Greater Bay Area. With strong policy and funding support from the HKSAR government, Hong Kong will further serve as a bridge connecting Mainland China and global tech partnerships, solidifying its leadership in life sciences innovation."Ahead of BIO 2025, the delegation participated in the "2025 Biomedical Pitch Competition", co-organized by the Boston Capital Investment Club (BCIC) and HKSTP. The event connects global life and health innovators with investors and business partners. Three HKSTP companies—ARBELE, GenEditBio, and Cogsmart—excelled in the preliminary rounds, competing against over 100 global life sciences firms, with ARBELE, HKUMed's affiliated spin-off company, winning the championship, underscoring Hong Kong's research excellence. Over the past three years, this platform has helped startups secure over USD 100 million in funding and connect with hundreds of international investors and partners, driving further business growth.HKSTP is committed to propelling Hong Kong's life sciences sector onto the global stage, showcasing the city's unique strengths to attract international enterprises and talent. The delegation also organized networking events and visits, enabling Hong Kong companies to engage with overseas investors, leading corporations, and renowned academic institutions, including visits to MIT Professor Robert Langer (Described as "Edison of Medicine"), Harvard Innovation Labs, Cambridge Innovation Center, and more. This initiative reinforces Hong Kong's sustainable development in life sciences and its role as a global innovation leader.Hashtag: #HKSTP
The issuer is solely responsible for the content of this announcement.
About Hong Kong Science and Technology Parks Corporation
Hong Kong Science and Technology Parks Corporation (HKSTP) was established in 2001 to create a thriving I&T ecosystem grooming 13 unicorns, more than 15,000 research professionals and over 2,300 technology companies from 25 countries and regions focused on developing healthtech, AI and robotics, fintech and smart city technologies, etc.
Our growing innovation ecosystem offers comprehensive support to attract and nurture talent, accelerate and commercialise innovation for technology ventures, with the I&T journey built around our key locations of Hong Kong Science Park in Pak Shek Kok, InnoCentre in Kowloon Tong and three modern InnoParks in Tai Po, Tseung Kwan O and Yuen Long realising a vision of new industrialisation for Hong Kong, where sectors including advanced manufacturing, micro-electronics and biotechnology are being reimagined.
Hong Kong Science Park Shenzhen Branch in Futian, Shenzhen plays positive roles in connecting the world and the mainland with our proximity, strengthening cross-border exchange to bring advantages in attracting global talent and allowing possibilities for the development of technology companies in seven key areas: Medtech, big data and AI, robotics, new materials, microelectronics, fintech and sustainability, with both dry and wet laboratories, co-working space, conference and exhibition facilities, and more.
Through our R&D infrastructure, startup support and enterprise services, commercialisation and investment expertise, partnership networks and talent traction, HKSTP continues to contribute in stablishing I&T as a pillar of growth for Hong Kong. More information about HKSTP is available at www.hkstp.org.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malay Mail
2 hours ago
- Malay Mail
Trump expected to extend TikTok sale deadline again amid ongoing uncertainties
SAN FRANCISCO, June 18 — US President Donald Trump is widely expected to extend the Thursday deadline for TikTok to find a non-Chinese buyer or face a ban in the United States. It would be the third time Trump put off enforcing a federal law requiring its sale or ban, which was to take effect the day before his January inauguration. 'I have a little warm spot in my heart for TikTok,' Trump said in an NBC News interview in early May. 'If it needs an extension, I would be willing to give it an extension.' Trump said a group of purchasers is ready to pay TikTok owner ByteDance 'a lot of money' for the video-clip-sharing sensation's US operations. Trump has repeatedly downplayed risks that TikTok is in danger, saying he remains confident of finding a buyer for the app's US business. The president is 'just not motivated to do anything about TikTok,' said independent analyst Rob Enderle. 'Unless they get on his bad side, TikTok is probably going to be in pretty good shape.' Trump had long supported a ban or divestment, but reversed his position and vowed to defend the platform after coming to believe it helped him win young voters' support in the November election. 'Trump's not really doing great on his election promises,' Enderle maintained. 'This could be one that he can actually deliver on.' Digital Cold War? Motivated by national security fears and belief in Washington that TikTok is controlled by the Chinese government, the ban took effect on January 19, one day before Trump's inauguration, with ByteDance having made no attempt to find a suitor. TikTok 'has become a symbol of the US-China tech rivalry; a flashpoint in the new Cold War for digital control,' said Shweta Singh, an assistant professor of information systems at Warwick Business School in Britain. 'National security, economic policy, and digital governance are colliding,' Singh added. The Republican president announced an initial 75-day delay of the ban upon taking office. A second extension pushed the deadline to June 19. As of Monday, there was no word of a TikTok sale in the works. Tariff turmoil Trump said in April that China would have agreed to a deal on the sale of TikTok if it were not for a dispute over tariffs imposed by Washington on Beijing. ByteDance has confirmed talks with the US government, saying key matters needed to be resolved and that any deal would be 'subject to approval under Chinese law'. Possible solutions reportedly include seeing existing US investors in ByteDance roll over their stakes into a new independent global TikTok company. Additional US investors, including Oracle and private equity firm Blackstone, would be brought on to reduce ByteDance's share in the new TikTok. Much of TikTok's US activity is already housed on Oracle servers, and the company's chairman, Larry Ellison, is a longtime Trump ally. Uncertainty remains, particularly over what would happen to TikTok's valuable algorithm. 'TikTok without its algorithm is like Harry Potter without his wand—it's simply not as powerful,' said Forrester Principal Analyst Kelsey Chickering. Meanwhile, it appears TikTok is continuing with business as usual. TikTok on Monday introduced a new 'Symphony' suite of generative artificial intelligence (AI) tools for advertisers to turn words or photos into video snippets for the platform. 'With TikTok Symphony, we're empowering a global community of marketers, brands, and creators to tell stories that resonate, scale, and drive impact on TikTok,' global head of creative and brand products Andy Yang said in a release. — AFP
The Sun
8 hours ago
- The Sun
HKSTP Teams Up with HKU and CUHK Medical Schools to Showcase Hong Kong's Life & Health Innovations at BIO International Convention
HONG KONG SAR - Media OutReach Newswire - 17 June 2025 - Hong Kong Science and Technology Parks Corporation (HKSTP), in collaboration with InvestHK, led 16 prominent life and health technology companies to BIO 2025, the world's largest biotechnology event, held in Boston, USA, from June 16 to 19. This year marks the first time HKSTP joined forces with Hong Kong's two leading medical faculties—the LKS Faculty of Medicine at The University of Hong Kong (HKU) and the Faculty of Medicine at The Chinese University of Hong Kong (CUHK) - to form a delegation, showcasing Hong Kong's cutting-edge research capabilities and innovation potential in life sciences and health technologies. The initiative further strengthens Hong Kong's position as a world-class biotech innovation hub. The HKSTP Pavilion highlighted the groundbreaking technologies and products of its park companies, featuring innovative solutions across diverse fields such as novel drug development, diagnostic technologies, and medical innovation. Among the 16 participating companies, they were the members of HKSTP's incubation programmes including Incu-Bio and ELITE Programme, cutting-edge work from the InnoHK research centers, and other outstanding biotech companies. On the first day of the exhibition, the delegation successfully attracted attention from global industry leaders, corporate partners, and venture capital firms. During BIO 2025, HKSTP and its park companies made significant strides in fostering cross-border innovation ecosystems and exploring new market opportunities: • Immuno Cure, partnering with HKUMed, the developer of the first-in-human novel therapeutic HIV vaccine ICVAX, announced its collaboration with PharmaJet to explore the application of a needle-free vaccination solution, accelerating the global commercialization pathway for ICVAX. • HKSTP signed a partnership agreement with DLRC to provide legal advisory services in clinical trials and certification, promoting global ecosystem collaboration and growth. Mr. Albert Wong, CEO of HKSTP, said: 'We are thrilled to partner with two leading medical schools for the first time at BIO 2025, demonstrating Hong Kong's breakthroughs and innovation in life and health technology. This delegation not only deepens collaboration between Hong Kong and top global research institutions but also highlights our unique advantages as a core I&T hub in the Greater Bay Area. With strong policy and funding support from the HKSAR government, Hong Kong will further serve as a bridge connecting Mainland China and global tech partnerships, solidifying its leadership in life sciences innovation.' Ahead of BIO 2025, the delegation participated in the '2025 Biomedical Pitch Competition', co-organized by the Boston Capital Investment Club (BCIC) and HKSTP. The event connects global life and health innovators with investors and business partners. Three HKSTP companies—ARBELE, GenEditBio, and Cogsmart—excelled in the preliminary rounds, competing against over 100 global life sciences firms, with ARBELE, HKUMed's affiliated spin-off company, winning the championship, underscoring Hong Kong's research excellence. Over the past three years, this platform has helped startups secure over USD 100 million in funding and connect with hundreds of international investors and partners, driving further business growth. HKSTP is committed to propelling Hong Kong's life sciences sector onto the global stage, showcasing the city's unique strengths to attract international enterprises and talent. The delegation also organized networking events and visits, enabling Hong Kong companies to engage with overseas investors, leading corporations, and renowned academic institutions, including visits to MIT Professor Robert Langer (Described as 'Edison of Medicine'), Harvard Innovation Labs, Cambridge Innovation Center, and more. This initiative reinforces Hong Kong's sustainable development in life sciences and its role as a global innovation leader. Appendix: List of Park Companies Participating in BIO 2025: 1. Allegrow Biotech Limited 2. ARBELE Limited 3. Beth Bioinformatics Co., Limited 4. Centre for Translational Stem Cell Biology 5. The Centre for Virology, Vaccinology, and Therapeutics 6. DECODE CURE Limited 7. GenEditBio Limited 8. Great Bay Bio 9. Hong Kong Universal Biologicals Company Limited 10. Immuno Cure Holding (HK) Limited 11. The Institute for Innovation, Translation and Policy Research (ITPR) 12. LEE'S PHARMACEUTICAL (HK) LIMITED 13. Serilink Biotechnology Company Limited 14. Xiaomo Biotech Limited 15. XUXIN (HongKong) Biotechnology Co., Limited 16. Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Limited Hashtag: #HKSTP
The Sun
9 hours ago
- The Sun
Chubb Life Hong Kong Launches Chubb 1792 Club, a Prestigious Global Wealth Centre Designed to Elevate Customer Experience
HONG KONG SAR - Media OutReach Newswire - 16 June 2025 - Chubb Life Hong Kong (Chubb Life HK) today unveiled its first wealth centre, Chubb 1792 Club, marking a pivotal moment in its insurance and wealth management journey. Located at The Gateway in Tsim Sha Tsui, a premier business and tourism district in Hong Kong, Chubb 1792 Club aims to serve the increasing health and wealth needs of affluent customers and high-net-worth individuals in Hong Kong and visitors to the city. The launch of Chubb 1792 Club marks a key milestone for Chubb Life HK as the city cements its position as a global insurance and wealth management powerhouse, attracting affluent and high-net-worth customers with a wide range of innovative insurance and financial offerings. By the end of 2023, the asset and wealth management sector in Hong Kong reached HK$31.2 trillion (US$3.97 trillion), with 64% of them sourced from non-Hong Kong residents. The growth trend is particularly evident in the life insurance sector, which saw record-breaking sales in 2024 as both local residents and mainland Chinese visitors sought protection and wealth management solutions. Notably, mainland Chinese visitors spent HK$62.8 billion(US$8 billion) in 2024, mainly on life, critical illness and medical policies— a 6.5% increase from the previous year. Spanning nearly 10,000 square feet, Chubb 1792 Club is thoughtfully designed to encourage meaningful engagement through art. With a longstanding history of safeguarding possessions, lives, and heritage through comprehensive insurance solutions, Chubb Life HK is committed to preserving the enduring value of what matters most. Chubb 1792 Club extends the company's commitment to enhancing customer experiences through a thoughtfully curated space showcasing art pieces by local and international artists. Over the past two years, the company launched a Chubb Life Art Gallery and expanded its partnership with Art Basel Hong Kong and M+ Museum as part of its ongoing effort to support the art community. Curated by ART021 Group, China's largest contemporary art fair group, Chubb 1792 Club features a selection of artworks by eight artists: Yang Yongliang, Desmond Leung Kar Hao, Stephen Wong Chun Hei, Wolfgang Tillmans, Annie Morris, Abraham Lacalle, Long Quan, and Lu Pingyuan. Belinda Au, President of Chubb Life Hong Kong and Head of North Asia, said, 'Chubb 1792 Club is an extraordinary space that embodies our commitment to offering experiences that serve the evolving needs of affluent and high-net-worth customers. We are proud to offer a unique platform that blends wealth expertise with cultural storytelling, empowering our customers, partners, and communities to build lasting legacies.' The design of the Chubb 1792 Club draws from the theme of water, symbolising vitality and connection while honouring Chubb's maritime heritage. Elements of water – the gentlest existence between heaven and earth, shapeless yet shaping all things, silent yet telling countless stories flows through the space, presenting a narrative about water, life, and protection. Fluid architectural forms echo the ebb and flows of the sea, while nautical design cues such as structural curvature reinforce a seamless connection to the brand's maritime legacy.
